NCT02465593 A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02460822 Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management Status COMPLETED Phase NA
NCT02437656 Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer. Status COMPLETED Phase PHASE2
NCT02435758 Multicenter Study on Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery Status COMPLETED Phase NA
NCT02421432 Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases Status UNKNOWN Phase NA
NCT02406118 Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME Status UNKNOWN Phase NA
NCT02403505 Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02399813 A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal Status COMPLETED Phase PHASE2
NCT02371304 Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers Status UNKNOWN Phase PHASE3
NCT02353858 Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT02340949 Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT02311803 Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery Status UNKNOWN Phase NA
NCT02293954 Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT02288078 Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) Status UNKNOWN Phase PHASE2
NCT02280070 RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). Status UNKNOWN Phase PHASE2